Navigation Links
Merz Pharmaceuticals Announces Results of Clinical Trials with NT-201(Botulinum neurotoxin type A free from complexing proteins) at Annual Movement Disorders Society Meeting
Date:6/8/2009

--First of 2 data sets to be released--

PARIS, June 8 /PRNewswire/ -- Results from two randomized, active-controlled clinical trials in patients with blepharospasm and cervical dystonia -- one placebo-controlled spasticity trial and one upper limb spasticity trial -- were presented at the Movement Disorder Society (MDS) 13th annual International Congress in Paris, France. The studies were sponsored by Merz Pharmaceuticals, which plans to file a Biologic License Application (BLA) for NT-201 in the USA in the near future.

"The results of these studies reaffirm our beliefs that NT-201 (Xeomin(R); botulinum neurotoxin free from complexing proteins), can be used to potentially aid focal dystonia and post-stroke spasticity sufferers," said Eric Pappert, M.D., Vice President of Medical Affairs, Merz Pharmaceuticals, USA. "In addition, NT-201 showed results in treating upper limb spasticity sufferers of various etiologies including stroke, brain injury, spinal cord injury, multiple sclerosis or cerebral palsy, warranting additional studies as a potential treatment option for a wide scope of patients."

NT-201 is a neurotoxin therapy free from complexing proteins due to a combination of high biologic activity with low bacterial protein load. It has been approved for marketing in Europe since 2007 to treat various movement disorders, and more recently approved in Canada for the indications of symptomatic management of blepharospasm, cervical dystonia and post-stroke spasticity of the upper limb. "Studies in Europe have shown non-inferiority of NT-201 to one other botulinum toxin in the treatment of cervical dystonia," said Pappert.

First Study - Title

Overall clinical efficacy and overall tolerability of NT-201 (Xeomin(R); botulinum neurotoxin free from complexing proteins) authored by R. Benecke, S. Grafe, I. Sassin, and G. Comes.

Method

Efficacy i
'/>"/>

SOURCE Merz Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Arena Pharmaceuticals Announces Lorcaserin Data Demonstrating Highly Significant Categorical and Absolute Weight Loss and Improvements in Secondary Endpoints Associated with Cardiovascular Risk
2. Access Pharmaceuticals Announces Publication of Thiarabine Combination Data
3. Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials
4. Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Associations 69th Scientific Sessions
5. Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
6. Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
7. Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401s Activity in the Treatment of Advanced Metastatic Renal Cell Cancer
8. Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer
9. Kinex Pharmaceuticals To Present at ASCO 2009 Annual Meeting
10. TRACON Pharmaceuticals Small Molecule TRC102 and Antibody TRC105 to be Presented at ASCO 2009
11. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...MOUNTAINVIEW,Calif.,Nov.25/PRNewswire/-- ChemoCen...afromtheCompany,sPROTECT-1(theProspectiveRandomize...icet-EN(TM)(CCX282-B)inpatientswithmoderate-to-sev...favorablesafetyandtolerabilityprofile.Thestudydemo...diseaseseverityasdefinedasa70-pointdecreaseintheCr...
(Date:11/24/2009)...FREMONT,Calif.,Nov.24/PRNewswire-FirstCall/--Vermi...anyfileditsPlanofReorganizationandDisclosureStatem...ptcyCourtfortheDistrictofDelaware.Ahearingtoconsid...uledforDecember8,2009,withthehearingontheconfirmat...ancallsfortheCompanytopayallclaimsinfull.ThePlanis...
(Date:11/24/2009)...SANDIEGO,Nov.24/PRNewswire/--Accumetrics,Inc.,apri...;System,thefirstrapidandeasy-to-usediagnosticsyste...lateletagents(e.g.Plavix®andaspirin),announce...ics,andGregoryJ.Tibbitts,ChiefFinancialOfficerofAc...1stAnnualPiperJaffrayHealthCareConferencebeingheld...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Accumetrics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Debiopharm and MSM Protein Technologies Sign Agreement for Research and Development of Debio 0929 a Novel Oncology Biologic 13270 1Debiopharm and MSM Protein Technologies Sign Agreement for Research and Development of Debio 0929 a Novel Oncology Biologic 13270 2Debiopharm and MSM Protein Technologies Sign Agreement for Research and Development of Debio 0929 a Novel Oncology Biologic 13270 3Debiopharm and MSM Protein Technologies Sign Agreement for Research and Development of Debio 0929 a Novel Oncology Biologic 13270 4Aztech Controls Introduces Standardized Gas Sticks for Semiconductor Tool Hook Up 13268 1Aztech Controls Introduces Standardized Gas Sticks for Semiconductor Tool Hook Up 13268 2Aztech Controls Introduces Standardized Gas Sticks for Semiconductor Tool Hook Up 13268 3New Custom Hybrid Planetary Gearbox Series from NMB 53182 1New Custom Hybrid Planetary Gearbox Series from NMB 53182 2
...Iceland, March 16 In a paper,published online tod...sts,detail a major mechanism through which genetic...s. In its work on the inherited components of doze...variants that significantly,affect individual susc...ommon forms of these conditions -- such as obesity...
..., N.J., March 15 Data presented at,the annual mee...mmunology,(AAAAI) suggests that the continuous use...nolone acetonide) Nasal Spray had no treatment eff... aged 2-5 years old with,year-round allergic rhini...ds in the treatment of very,young children with al...
Other Medicine Technology:deCODE Obesity Study Sheds Light on How Genetics Affects Risk and Onset of Common Diseases 2deCODE Obesity Study Sheds Light on How Genetics Affects Risk and Onset of Common Diseases 3New Trial Presented at AAAAI Reports that the Growth of Children 2-5 Years Old with Year-Round Allergic Rhinitis Continued According to Normal Age-Adjusted Distribution Over a 6-Month Treatment with Nasacort AQ 2New Trial Presented at AAAAI Reports that the Growth of Children 2-5 Years Old with Year-Round Allergic Rhinitis Continued According to Normal Age-Adjusted Distribution Over a 6-Month Treatment with Nasacort AQ 3New Trial Presented at AAAAI Reports that the Growth of Children 2-5 Years Old with Year-Round Allergic Rhinitis Continued According to Normal Age-Adjusted Distribution Over a 6-Month Treatment with Nasacort AQ 4
(Date:11/25/2009)... Evaluation and treatment cl... Woodstock (Vocus) November 25, 2009 -- Ce...asal vaccines and H1N1 vaccine shots at four Cente...nother shipment of vaccine has arrived. The clinic...Lake and McHenry and will be open as follows: , ...
(Date:11/25/2009)..., NEWYORK,Nov.25/PRNewswire/-- MISSIONSkincare ...1millionforSt.Jude.AspartofGNC,sannualSt.Jude Than... MISSIONSkincare,s new SUPER-C(TM)LipBalm willbe...pportunitytomakea$1,$5or$10donationatcheckoutatone...raisemorethan$1millionforSt.Judeduringtheir2009 Th...
(Date:11/25/2009)... drug used to treat colorectal cancer also can rev...red first-line therapy for the disease, researcher...his week. , Mntrier,s disease causes thickening o...a and vomiting, as well as anemia and swelling in ...are at increased risk for gastric cancer. Previous...
(Date:11/25/2009)... Nationwide Imaging Services...ganizations for diagnostic imaging equipment, now ..., including financing options, service and install...a Atlas Medical Technologies of California) , ..., 2009 -- Nationwide Imaging Services is proud to ...
(Date:11/25/2009)..., WorkingTogethertoShareRecordsSafely,Improve...re/--TheDepartmentofVeteransAffairs(VA)andKaiserPe...mprovecareandservicestoourNation,sheroes.VAandKais...ctronichealthrecord(EHR)informationusingtheNationw...tmentofHealthandHumanServices. ,, "Theabilityto...
Breaking Medicine News(10 mins):Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 3Health News:VA and Kaiser Permanente Invite Veterans to Participate in Health Record Pilot Program 2
...ther is just around the corner, but before familie...a crackling campfire or burn yard debris, they sho... out a serious childhood health risk. , Universit... foot and ankle burns in the southeastern United S...
...Systems, a premier,provider of integrated professi...s goals of healthcare organizations, announced tod...alth Inc. (La Plata, Maryland), to,provide informa...ice Center in Dallas, Texas, while also providing ...
...anada and Japan have uncovered some remarkable res...tuations very differently. , Across two studies,...ed of one centre model and four background models ...ermine the dominant emotion of the centre figure. ...
...of Health Dr.,Calvin B. Johnson today met with hea...dical Clinic in Sharon and ERASE Coalition/Minorit...ard G. Rendell,s plan to provide,access to health ...to help prevent disease,successfully manage chroni...
...lth Resources,and Services Administration (HRSA) a... (HHS) today proposed a new rule that will improve...ignated and target federal,resources to the people...d populations (MUPs) and,health professional short...
...ding global research,organization, is proud to ann...linical Researcher of the Year ceremony, including...hiltern received the following awards: Gold: Clin...iate category Silver: Donna Sexton in Clinical Re...
Other Medicine News:Health News:UF researchers warn parents about dangers of childhood foot burns 2Health News:UF researchers warn parents about dangers of childhood foot burns 3Health News:Civista Health Inc. Selects Phoenix Health Systems for Information Technology Outsourcing Services 2Health News:When it comes to emotions, Eastern and Western cultures see things very differently: Study 2Health News:Pennsylvania Health Secretary Visits Mercer County to Call for Health Insurance for All Pennsylvanians 2Health News:HRSA Proposes Rule to Revise, Combine HPSAs, MUPs 2Health News:Chiltern Wins Top Prize 2
Langenbeck Periosteal Elevators
Cushing Periosteal Elevator
Lederer Periosteal Elevators
Miller Collburn Periosteal Elevators
Medicine Products: